Pfizer Inc (PFE)

35.11
NYSE : Health Care
Prev Close 35.11
Day Low/High 0.00 / 0.00
52 Wk Low/High 28.25 / 37.39
Avg Volume 22.04M
Exchange NYSE
Shares Outstanding 6.07B
Market Cap 211.21B
EPS 1.10
P/E Ratio 15.68
Div & Yield 1.20 (3.40%)

Latest News

Mylan, Trump and Tons of Huge Corporations Have Donated to the Clinton Foundation

Mylan, Trump and Tons of Huge Corporations Have Donated to the Clinton Foundation

Pretty much every company you can think of has donated to the Clinton Foundation. So has Donald Trump. Should it matter?

Jim Cramer's 'Mad Money' Recap: Markets Make This Economy, Not the Fed

Jim Cramer's 'Mad Money' Recap: Markets Make This Economy, Not the Fed

Cramer says he doesn't understand the obsession some investors have with the Federal Reserve. Forget the Fed.

Pfizer (PFE) Stock Earnings Estimates Raised at Jefferies on $14 Billion Medivation Deal

Pfizer (PFE) Stock Earnings Estimates Raised at Jefferies on $14 Billion Medivation Deal

Jefferies increased its 2016 and 2017 earnings estimates for Pfizer (PFE) after the pharmaceutical company said it is purchasing Medivation (MDVN) for $14 billion.

Sniffing Out New Investments During 'Dog Days'

Now's a good time to look for ideas.

Portfolio Manager: Is Pfizer Acquiring Too Quickly?

Portfolio Manager: Is Pfizer Acquiring Too Quickly?

Pfizer's second acquisition this week could add risk. Some retailers attract portfolio managers.

Crude Oil, Health Care Team Up to Pull Wall Street Lower

Crude Oil, Health Care Team Up to Pull Wall Street Lower

A selloff in crude oil and health care stocks led Wall Street into the red on Wednesday.

Stocks Extend Decline as Crude Falls to One-Week Low

Stocks Extend Decline as Crude Falls to One-Week Low

Stocks hold slightly lower by mid-afternoon Wednesday as a greater build to inventories accelerates losses in crude oil.

Pfizer Strikes Deal With AstraZeneca for Rights to Antibiotics Businesses

Pfizer Strikes Deal With AstraZeneca for Rights to Antibiotics Businesses

The pharmaceutical giant says it has inked a deal for the development rights of some growing antibiotics businesses.

European Markets Mixed as Volatility Hits 17-Month Low

European Markets Mixed as Volatility Hits 17-Month Low

Mining stocks pull down London's benchmark index.

Stocks Hold Losses as Crude Oil Extends Decline

Stocks Hold Losses as Crude Oil Extends Decline

Stocks hold slightly lower by mid-afternoon Wednesday as a greater build to inventories accelerates losses in crude oil.

Pfizer's Latest Acquisition Could Add to Integration Risk

But we maintain the company is attractive to purchase for the secure, 3.4% dividend yield.

Pfizer Is Buying a Portion of AstraZeneca's Antibiotics Business

Pfizer Is Buying a Portion of AstraZeneca's Antibiotics Business

Pfizer is making another acquisition.

Why Pfizer's Latest Deal Could Send Its Shares Soaring

Why Pfizer's Latest Deal Could Send Its Shares Soaring

The acquisition of Medivation gives the pharma giant a top-selling oncology drug and an immediate profit boost.

Stock Futures Little Changed in Wait for Friday's Yellen Speech

Stock Futures Little Changed in Wait for Friday's Yellen Speech

Stock futures remain close to the flatline on Wednesday as investors await a critical speech from Federal Reserve Chair Janet Yellen at the end of the week.

Earthquake in Central Italy Keeps Markets Cautious, Dozens Killed

Earthquake in Central Italy Keeps Markets Cautious, Dozens Killed

Pescara Del Tronto was one of the hardest hit towns in Central Italy as an earthquake rattled the country overnight.

Pfizer Picks Up AstraZeneca's Antibiotics Business

Pfizer Picks Up AstraZeneca's Antibiotics Business

The deal could be worth $1.5 billion.

5 Things You Must Know Before the Market Opens Wednesday

5 Things You Must Know Before the Market Opens Wednesday

Pfizer buys antibiotics business from AstraZeneca; Tesla unveils Model S version that can go 300 miles on a single charge; U.S. stock futures rise slightly.

European Markets Steady; Italy Hit by Earthquake

European Markets Steady; Italy Hit by Earthquake

Central part of Italy hit by 6.2 magnitude earthquake.

Pfizer To Acquire Small Molecule Anti-Infective Business From AstraZeneca

Pfizer To Acquire Small Molecule Anti-Infective Business From AstraZeneca

Pfizer Inc. (NYSE:PFE) today announced that it has entered into an agreement with AstraZeneca to acquire the development and commercialization rights to its late-stage small molecule anti-infectives business, primarily...

Bristol-Myers Squibb And Pfizer To Present New Eliquis (apixaban) Analyses At ESC Congress 2016

Bristol-Myers Squibb And Pfizer To Present New Eliquis (apixaban) Analyses At ESC Congress 2016

Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc.

Jim Cramer's 'Mad Money' Recap: I'm Watching Best Buy, PVH, Yellen This Week

Jim Cramer's 'Mad Money' Recap: I'm Watching Best Buy, PVH, Yellen This Week

Earnings season is far from over, Cramer says, and the Fed chief gives a major speech Friday.

Market Keeps Chasing Its Own Tail

Stocks travel a good distance just to end up nowhere.

Stocks Waver as Investors Wait for Fed Clarity

Stocks Waver as Investors Wait for Fed Clarity

Wall Street will get more clues on the Fed's rate hike plans later this week, but uncertainty over what they might be led to jittery trading on Monday.

Stocks Struggle for Direction as Jackson Hole Conference Looms

Stocks Struggle for Direction as Jackson Hole Conference Looms

Stocks fluctuate Monday afternoon as a selloff in crude oil hits the energy sector and Federal Reserve speeches at the end of the week leave investors wary.

Medivation Scores Premium in Sale to Pfizer

Medivation Scores Premium in Sale to Pfizer

Shareholders of the oncology drug maker ought to be satisfied with the auction's conclusion.

Cramer: A Bunch of Semis Are Ripe for the Picking

Cramer: A Bunch of Semis Are Ripe for the Picking

That's the hot spot in M&A right now.

Cyclacel Stock Runs on Momentum Rocket Fueled by 'Dumb & Dumber' Optimism

Cyclacel Stock Runs on Momentum Rocket Fueled by 'Dumb & Dumber' Optimism

Shares of biotech micro-cap Cyclacel Pharmaceuticals have doubled in price in the past 10 days. Call it the Lloyd Christmas effect.

Pfizer's Deal to Buy Medivation May Give the Company Its Groove Back

Pfizer's Deal to Buy Medivation May Give the Company Its Groove Back

Pfizer's $14 billion acquisition of Medivation is a strong purchase, according to Jim Cramer, who now wonders what Sanofi will do next.